businesspress24.com - Insight Into Market Ahead - Equity Research on Gilead Sciences, Inc. and Bristol Myers Squibb Co.
 

Insight Into Market Ahead - Equity Research on Gilead Sciences, Inc. and Bristol Myers Squibb Co.

ID: 1031755

(firmenpresse) - HONG KONG -- (Marketwire) -- 08/18/11 -- Today, released its industry report highlighting Gilead Sciences, Inc. (NASDAQ: GILD) and Bristol Myers Squibb Co. (NYSE: BMY). Full fundamental and technical analysis is available at .

Continued confidence in long-term U.S. debt is defying S&P's recent downgrade. Treasury yields continue at their lowest levels since January 1, 2011 as the market moved to "safe investments" weary of the storm clouds ahead. Winds can change however, as a last-minute move to save the U.S. from a historic default on its debt obligations. Attentions are now turned to the situation in Europe, with the health of the Euro in the balance; bankers are looking to prevent defaults on Italian and Spanish debt.

As a result of recent credit adjustments, opportunity is being marked for investors to take advantage of equities with high-margin and specialty products. Market-wise investors are carefully watching for value within equities boasting established pipelines and excellent growth prospects. As part of this process, the following companies have been introduced with initial research reports available online.

World Street Fundamentals has highlighted Gilead Sciences, Inc. as a biopharmaceutical company. The Company focuses on the development and commercialization of human therapeutics for life threatening diseases. The Company has operations in North America, Europe and Asia Pacific. The entire report on Gilead Sciences, Inc. (NASDAQ: GILD) is available here: .

World Street has featured Bristol Myers Squibb Co. as a company which is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceutical products on a global basis. The Company's products are sold worldwide, primarily to wholesalers, retail pharmacies, hospitals, government entities and the medical profession. The entire report on Bristol Myers Squibb Co. (NYSE: BMY) is available here: .

About World Street




World Street Fundamentals is an online portal for professionals, investors and new-comers to the markets to find in depth comprehensive research and research tools to help guide you through the ever changing financial markets.



Contact:

Adam Redford


Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:



drucken  als PDF  an Freund senden  Global Situation & Resulting Influences - Research Report on Alcoa Inc. and Vale
Garda First in North America to Provide Clients With SSAE No.16 and CSAE 3416 Certification of Rigorous Controls Safeguarding Their Assets and Information
Bereitgestellt von Benutzer: MARKET WIRE
Datum: 18.08.2011 - 07:00 Uhr
Sprache: Deutsch
News-ID 1031755
Anzahl Zeichen: 0

contact information:
Contact person:
Town:

HONG KONG


Phone:

Kategorie:

Commercial & Investment Banking


Anmerkungen:


Diese Pressemitteilung wurde bisher 94 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Insight Into Market Ahead - Equity Research on Gilead Sciences, Inc. and Bristol Myers Squibb Co.
"
steht unter der journalistisch-redaktionellen Verantwortung von

World Street Fundamentals (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von World Street Fundamentals



 

Who is online

All members: 10 568
Register today: 0
Register yesterday: 1
Members online: 0
Guests online: 90


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.